Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000950103-10-003267)

Filing Details

Accession Number:: 0000950103-10-003267
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-11-05 14:09:02
Reporting Period:: 2010-11-04

Filing Date:: 2010-11-05
Accepted Time:: 2010-11-05 14:09:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1013238	Aradigm Corp	ARDM	Electromedical & Electrotherapeutic Apparatus (3845)	943133088

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
353278	S A Nordisk Novo	Novo Alle Dk 2880 Bagsvaerd G7 00000		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, No Par Value	Disposition	2010-11-04	225,000	$0.17	26,605,591	No	4	S	Indirect	By Novo Nordisk Inc.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Novo Nordisk Inc.

Footnotes

The securities were sold in 1 trade lot with a price of USD 0.1697 per share.
Novo Nordisk Inc. is a wholly-owned subsidiary of Novo Nordisk A/S. Novo Nordisk A/S directly holds 26,204,122 shares of common stock of Aradigm Corporation. In addition, Novo Nordisk Inc. holds 401,469 shares of common stock of Aradigm Corporation.